Tuesday, 11 May 2021, 4:34 pm
Medical professionals and groups are sounding growing
international concern around the use of puberty blockers to
treat young people with gender dysphoria because of the low
certainty of benefits, but the significant potential for
medical harm. Family First is calling on the New Zealand
government to pause the use of puberty blockers for
teenagers while further research is undertaken, a sentiment
supported by a majority of New Zealanders.
Sweden’s
leading gender clinic - Stockholm’s Astrid Lindgren
children’s hospital - has become the world’s first to end
routine treatment of minors under the age of 18 with